Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients

Kikuya Kato(Unknown), Fumio Imamura(Osaka International Cancer Institute)
Scientific Reports
July 6, 2016
10.1038/srep29093
Cited by 17

Related Papers

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2008|365
Monitoring gastric cancer progression with circulating tumour DNA
|British Journal of Cancer|2014|103
High-fidelity target sequencing of individual molecules identified using barcode sequences:<i>de novo</i>detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients
|DNA Research|2015|88
Usefulness of ultrathin bronchoscopy in diagnosis of lung cancer
|Lung Cancer|2004|58
Analytical Performance of a Highly Sensitive System to Detect Gene Variants Using Next-Generation Sequencing for Lung Cancer Companion Diagnostics
|Diagnostics|2023|26